Copyright
©The Author(s) 2004.
World J Gastroenterol. Apr 1, 2004; 10(7): 972-976
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.972
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.972
Table 3 Sequential changes and comparisons of serum ferritin levels (μg/L) at different time points during lamivudine treatment in HBeAb-negative and -positive groups at end of treatment
Group | Baseline | Months after treatment | ||
3 | 6 | 12 | ||
HBV DNA ( - ) group (n = 10) | 249.19 ± 176.48 | 147.33 ± 147.60 | 114.47 ± 76.62 | 104.41 ± 78.60 |
HBV DNA ( + ) group (n = 28) | 195.07 ± 137.31 | 159.74 ± 96.94 | 129.85 ± 72.26 | 134.61 ± 87.51 |
P values | 0.328 | 0.765 | 0.577 | 0.346 |
- Citation: Liu ZW, Han QY, Zhang N, Kang W. Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B. World J Gastroenterol 2004; 10(7): 972-976
- URL: https://www.wjgnet.com/1007-9327/full/v10/i7/972.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i7.972